[1]  Akari, P., Chatterjee, C., & Higgins, M. J. (2024). Don’t Throw the Baby Out With the Bathwater: Firm Response to Downstream Product Shocks (NBER WP No. w32703). (Second revise & resubmit, Management Science).


[2] Mahendiran, S., Dukes, J. Anthony, Sokol, D. Daniel & Chatterjee, C. (2026). Enforcing Pharmaceutical Trademarks: The Role of Litigation in India (Revise & resubmit, Production and Operations Management). 


[3] Liu, Hanwen, Marra, Marianna, Rotolo, Daniele & Chatterjee, C. (2026). From Initiation to Integration: The Phased Emergence of China’s AI Industry Innovation System (2026).  (Minor revision, Industry & Innovation).


[4]  Chakrabarti, A. S., Chatterjee, C. & Gupta, S. (2024). Demonetization and Healthcare Expenditure (Second revise and resubmit, Journal of Economics and Management Strategy). 


[5] Agrawal, S., Bhattacharya, S., Chatterjee, S. & Chatterjee, C. (2024). Income shock and Women’s Health Spending: Evidence from India (forthcoming), Oxford Open Economics. Sussex Economics WP No. 13-2024. 


[6]  Agrawal, S., Rathi, S., Chatterjee, C., & Higgins, M. J. (2024). Do Stronger IPR Incentivize Female Participation in Innovation? Evidence from Chinese AI Patents (NBER WP No. w32547). (under review).


[7]   Cao, S., & Chatterjee, C. (2024). Equilibrium effects of pharmaceutical bundling: Evidence from India. SIEPR (Stanford) Working Paper 22-03. (under review)


[8]  Chatterjee, C. Fan, Ying, Mohapatra, D. M. (2024). Spillover Effects in Complementary Markets: A Study of the Indian Cellphone and Wireless Service Markets. Working Paper.


[9]  Chatterjee, C. Hanushek. Eric. A. & Mahendiran. Shreekanth. (2024). Can Greater Access to Education Be Inequitable? New Evidence from India’s Right to Education Act. NBER WP No. w27377.



*** Note: Email chirantan@gmail.com or access SSRN page for latest drafts. This space will be regularly updated with other upcoming projects.